# PNU 166148 in Treating Patients With Metastatic Solid Tumors

> **NCT00004076** · PHASE1 · UNKNOWN · sponsor: **University of Glasgow** · enrollment: 30 (estimated)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** mureletecan

## Key facts

- **NCT ID:** NCT00004076
- **Lead sponsor:** University of Glasgow
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1999-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004076, "PNU 166148 in Treating Patients With Metastatic Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00004076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*